EBITDA Summary of Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited's latest annual EBITDA in 2023 was 9.9 Billion ZAR , up 11.94% from previous year.
Aspen Pharmacare Holdings Limited's latest quarterly EBITDA in 2023 Q2 was 4.44 Billion ZAR , up 100.0% from previous quarter.
Aspen Pharmacare Holdings Limited reported an annual EBITDA of 9.5 Billion ZAR in 2022, down -1.24% from previous year.
Aspen Pharmacare Holdings Limited reported an annual EBITDA of 10.48 Billion ZAR in 2021, up 8.69% from previous year.
Aspen Pharmacare Holdings Limited reported a quarterly EBITDA of 5.85 Billion ZAR for 2023 Q4, down 0.0% from previous quarter.
Aspen Pharmacare Holdings Limited reported a quarterly EBITDA of 2.22 Billion ZAR for 2023 Q1, down -63.52% from previous quarter.

Annual EBITDA Chart of Aspen Pharmacare Holdings Limited (2023 - 2002)

Historical Annual EBITDA of Aspen Pharmacare Holdings Limited (2023 - 2002)

Year	EBITDA	EBITDA Growth
2023	9.9 Billion ZAR	11.94%
2022	9.5 Billion ZAR	-1.24%
2021	10.48 Billion ZAR	8.69%
2020	8.66 Billion ZAR	-7.78%
2019	7.26 Billion ZAR	-2.91%
2018	5.54 Billion ZAR	-10.52%
2017	9.81 Billion ZAR	26.73%
2016	9.5 Billion ZAR	4.3%
2015	9.4 Billion ZAR	-2.97%
2014	9.53 Billion ZAR	21.79%
2013	8.63 Billion ZAR	49.73%
2012	5.6 Billion ZAR	26.02%
2011	4.19 Billion ZAR	12.67%
2010	3.72 Billion ZAR	20.54%
2009	2.98 Billion ZAR	16.87%
2008	2.61 Billion ZAR	113.19%
2007	1.23 Billion ZAR	14.48%
2006	1.07 Billion ZAR	11.18%
2005	894.74 Million ZAR	27.61%
2004	493.42 Million ZAR	37.03%
2003	553.76 Million ZAR	23.92%
2002	446.85 Million ZAR	0.0%

Year	EBITDA	EBITDA Growth
2023 Q2	4.44 Billion ZAR	100.0%
2023 Q4	5.85 Billion ZAR	0.0%
2023 Q1	2.22 Billion ZAR	-63.52%
2022 Q4	6.09 Billion ZAR	124.22%
2022 Q1	2.37 Billion ZAR	-54.65%
2022 Q2	5.2 Billion ZAR	118.88%
2022 Q3	2.71 Billion ZAR	-47.81%
2022 FY	- ZAR	-1.24%
2021 Q1	2.7 Billion ZAR	-43.35%
2021 FY	- ZAR	8.69%
2021 Q2	5.69 Billion ZAR	110.35%
2021 Q3	2.26 Billion ZAR	-60.25%
2021 Q4	5.24 Billion ZAR	131.88%
2020 FY	- ZAR	-7.78%
2020 Q3	1.89 Billion ZAR	-65.7%
2020 Q2	5.53 Billion ZAR	154.02%
2020 Q1	2.17 Billion ZAR	-63.8%
2020 Q4	4.77 Billion ZAR	151.71%
2019 Q3	1.87 Billion ZAR	-65.22%
2019 FY	- ZAR	-2.91%
2019 Q4	6.01 Billion ZAR	221.17%
2019 Q1	1.9 Billion ZAR	-61.79%
2019 Q2	5.38 Billion ZAR	183.37%
2018 Q2	2.36 Billion ZAR	0.0%
2018 FY	- ZAR	-10.52%
2018 Q4	4.97 Billion ZAR	72.2%
2018 Q3	2.88 Billion ZAR	22.04%
2018 Q1	2.36 Billion ZAR	-10.56%
2017 Q3	2.64 Billion ZAR	0.68%
2017 Q1	2.62 Billion ZAR	-6.66%
2017 FY	- ZAR	26.73%
2017 Q4	2.64 Billion ZAR	0.0%
2017 Q2	2.62 Billion ZAR	0.0%
2016 Q2	2.6 Billion ZAR	0.0%
2016 FY	- ZAR	4.3%
2016 Q4	2.81 Billion ZAR	0.0%
2016 Q3	2.81 Billion ZAR	8.29%
2016 Q1	2.6 Billion ZAR	15.56%
2015 Q3	2.25 Billion ZAR	-32.84%
2015 Q4	2.25 Billion ZAR	0.0%
2015 FY	- ZAR	-2.97%
2015 Q1	3.35 Billion ZAR	46.88%
2015 Q2	3.35 Billion ZAR	0.0%
2014 Q1	2.41 Billion ZAR	-4.09%
2014 FY	- ZAR	21.79%
2014 Q4	2.28 Billion ZAR	0.0%
2014 Q3	2.28 Billion ZAR	-5.72%
2014 Q2	2.41 Billion ZAR	0.0%
2013 FY	- ZAR	49.73%
2013 Q4	2.52 Billion ZAR	0.0%
2013 Q3	2.52 Billion ZAR	55.36%
2013 Q2	1.62 Billion ZAR	0.0%
2013 Q1	1.62 Billion ZAR	13.48%
2012 Q1	1.37 Billion ZAR	26.4%
2012 Q3	1.43 Billion ZAR	4.2%
2012 FY	- ZAR	26.02%
2012 Q4	1.43 Billion ZAR	0.0%
2012 Q2	1.37 Billion ZAR	0.0%
2011 Q3	1.08 Billion ZAR	15.06%
2011 Q1	944.05 Million ZAR	0.0%
2011 Q4	1.08 Billion ZAR	0.0%
2011 Q2	944.05 Million ZAR	0.0%
2011 FY	- ZAR	12.67%
2010 Q4	944.05 Million ZAR	0.0%
2010 Q2	751.07 Million ZAR	0.0%
2010 FY	- ZAR	20.54%
2010 Q3	944.05 Million ZAR	25.69%
2010 Q1	751.07 Million ZAR	0.0%
2009 Q3	751.07 Million ZAR	24.41%
2009 FY	- ZAR	16.87%
2009 Q1	603.7 Million ZAR	0.0%
2009 Q4	751.07 Million ZAR	0.0%
2009 Q2	603.7 Million ZAR	0.0%
2008 FY	- ZAR	113.19%
2008 Q4	603.7 Million ZAR	0.0%
2008 Q3	603.7 Million ZAR	99.96%
2008 Q2	301.9 Million ZAR	0.0%
2008 Q1	301.9 Million ZAR	0.0%
2007 Q1	252.34 Million ZAR	0.0%
2007 Q2	252.34 Million ZAR	0.0%
2007 Q3	301.9 Million ZAR	19.64%
2007 FY	- ZAR	14.48%
2007 Q4	301.9 Million ZAR	0.0%
2006 Q3	252.34 Million ZAR	18.1%
2006 Q2	213.66 Million ZAR	0.0%
2006 Q1	213.66 Million ZAR	0.0%
2006 Q4	252.34 Million ZAR	0.0%
2006 FY	- ZAR	11.18%
2005 Q1	175.72 Million ZAR	0.0%
2005 FY	- ZAR	27.61%
2005 Q3	213.66 Million ZAR	21.59%
2005 Q4	213.66 Million ZAR	0.0%
2005 Q2	175.72 Million ZAR	0.0%
2004 Q1	132.11 Million ZAR	0.0%
2004 FY	- ZAR	37.03%
2004 Q3	175.72 Million ZAR	33.01%
2004 Q4	175.72 Million ZAR	0.0%
2004 Q2	132.11 Million ZAR	0.0%
2003 Q2	97.22 Million ZAR	0.0%
2003 Q4	132.11 Million ZAR	0.0%
2003 Q3	132.11 Million ZAR	35.88%
2003 FY	- ZAR	23.92%
2003 Q1	97.22 Million ZAR	0.0%
2002 FY	- ZAR	0.0%
2002 Q4	97.22 Million ZAR	0.0%
2002 Q3	97.22 Million ZAR	0.0%

Peer EBITDA Comparison of Aspen Pharmacare Holdings Limited

Name	EBITDA	EBITDA Difference

Global Stocks Search

Aspen Pharmacare Holdings Limited (APN.JO)

EBITDA Summary of Aspen Pharmacare Holdings Limited

Annual EBITDA Chart of Aspen Pharmacare Holdings Limited (2023 - 2002)

Historical Annual EBITDA of Aspen Pharmacare Holdings Limited (2023 - 2002)

Peer EBITDA Comparison of Aspen Pharmacare Holdings Limited